Shiga Toxin–Producing Escherichia coli and the Hemolytic–Uremic Syndrome
New England Journal of Medicine · 12.10.2023 · 389 (15) · 1402-1414
DOI: 10.1056/nejmra2108739 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 12.10.2023. Verfasst von Stephen B Freedman und 2 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Pediatrics and Emergency Medicine, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of …. Hauptthemen laut MEDLINE: Escherichia coli Infections, Hemolytic-Uremic Syndrome, Shiga-Toxigenic Escherichia coli. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 99 Literaturangaben.
Abstract (Originalsprache)
Shiga toxin–producing E. coli causes clinically important morbidity, particularly in children. Use of optimized diagnostics for identifying STEC and reporting toxin genotypes is essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Departments of Pediatrics and Emergency Medicine, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada (S.B.F.); the Department of Pediatric Nep…
ORCID-Profile: Stephen B Freedman, Nicole C A J van de Kar
Zitieren
APA
Freedman, S. B., van de Kar, N. C. A. J., & Tarr, P. I. (2023). Shiga Toxin–Producing Escherichia coli and the Hemolytic–Uremic Syndrome. New England Journal of Medicine, 389(15), 1402-1414. https://doi.org/10.1056/nejmra2108739
Vancouver
Freedman SB, van de Kar NCAJ, Tarr PI. Shiga Toxin–Producing Escherichia coli and the Hemolytic–Uremic Syndrome. New England Journal of Medicine. 2023;389(15):1402-1414. doi:10.1056/nejmra2108739
BibTeX
@article{Freedman2023,
author = {Freedman, Stephen B and van de Kar, Nicole C A J and Tarr, Phillip I},
title = {Shiga Toxin–Producing Escherichia coli and the Hemolytic–Uremic Syndrome},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {15},
pages = {1402--1414},
doi = {10.1056/nejmra2108739}
}
EUVIMED